This linear, covalently closed, double-stranded DNA offers a rapid, cell-free alternative to traditional plasmid DNA, addressing a critical bottleneck in nucleic acid therapeutics development
SPARK has extended its influence to an additional 9.47 million students worldwide
The Taipei facility boasts 10 GMP API production lines, with a total reactor volume exceeding 350,000 liters
COVIRIX Medical says its broad-spectrum antiviral portfolio has already shown positive virology results against key pandemic threats
Cadila Pharmaceuticals’ journey has been marked by several milestones, including the development of indigenous formulations, expansion into global markets, and the creation of robust manufacturing and R&D capabilities
The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission
Lilly has long voiced concerns over mass-compounded knockoffs of its tirzepatide medicines, Mounjaro and Zepbound
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
Phase I EPRAD study of DT-9081 demonstrated a favorable safety profile
Dr Severin Schwan was re-elected as Chairman of the Board with 97.75% of the votes
Subscribe To Our Newsletter & Stay Updated
